ICAD INC.
Company Snapshot
Founded: 1984
Entity Type: Public
Employees: 69
Region: U.S.
Revenue: $19.6 Millions
Revenue Year: 2024
Headquarter: New Hampshire, U.S.
Key Geographics: U.S.
Corporate Address: 98 Spit Brook Road, Suite 100, Nashua, New Hampshire 03062 U.S. Tel. +1-603-882-5200 www.icadmed.com
Company Overview
ICAD develops AI-powered solutions that enable healthcare providers to detect cancer in early stages accurately. The company’s ProFound Breast Health Suite is designed for AI-based analysis of mammography for breast cancer detection and risk evaluation. The solution is offered in over 50 countries. The product received regulatory clearance from the U.S. FDA, Health Canada and CE marking. The updated version of the iCAD ProFound Breast Health solution is under FDA review. It is designed using new deep-learning neural networks for breast cancer, density and risk assessments. The newly upgraded product will have increased specificity and sensitivity.
Financial Highlights (FY 2024)
Net Revenue: ***
Operating Income: ***
This information is available for BCC Research members only.
ICAD INC. In News
Company's Business Segments
- Product : PowerLook, ProFound AI, VeraLook, Xoft System
- Services : Support, Technical Assistance
Applications/End User Industries
- Healthcare
- Medical Imaging
- Radiology
- Oncology
- Medical Devices
- Clinical Research
BCC Research Beacon 